Affiliation:
1. Department of Microbiology Noakhali Science & Technology University, Sonapur Noakhali Bangladesh
2. Department of Biology Baylor University Waco Texas USA
3. Department of Biology University of Texas—Arlington Arlington Texas USA
4. Laboratory of Environmental Biology, Division of Environmental Health Sciences Wadsworth Center, New York State Department of Health Albany New York USA
5. Infectious Diseases Division icddr,b Dhaka Bangladesh
6. Department of Hematopathology Skims Tertiary Centre Hospital (STCH) Srinagar India
7. College of Medicine, Nursing, and Health Sciences University of Galway Galway Ireland
8. Evidence Synthesis Ireland and Cochrane Ireland University of Galway Galway Ireland
Abstract
The appropriate host cell immune responses for the progression of several diseases, including gastric or stomach cancer (GC), are significantly influenced by HLA polymorphisms. Our objective was to systematically review the evidence linking HLA polymorphisms with the risk of Helicobacter. pylori related GC. We conducted a comprehensive literature search to identify studies published between 2000 and April 2023 on the association of HLA polymorphisms with H. pylori related GC using databases such as Medline through PubMed, Embase, Web of Science (core collection), The Cochrane Library, and Scopus. Two authors independently screened articles, extracted data, and assessed the risk of bias using the Risk of Bias Assessment tool for Non‐randomized Studies. From 7872 retrieved studies, 19 met inclusion criteria, encompassing 1656 cases and 16,787 controls across four World Health Organization regions, with Japan contributing the most studies. We explored HLA‐A/B/C, HLA‐DRB1/DQA1/DQB1, HLA‐G, and MICA alleles. Of 29 significant HLA polymorphisms identified, 18 showed a positive association with GC, whereas 11 were negatively associated. HLA‐DQB1*06 allele was most frequently associated to susceptibility, as reported in four studies, followed by HLA‐DRB1*04 and HLA‐DQA1*01, each reported in two studies. Conversely, HLA‐G*01, HLA‐DQA1*01, HLA‐DQA1*05, and HLA‐DQB1*03 were identified as protective in two studies each. Additionally, five genotypes and six haplotypes were reported as positive, whereas three genotypes and two haplotypes were negative factors for the disease incidence or mortality. Despite heterogeneity in the study population and types of HLA polymorphisms examined, our analysis indicates certain polymorphisms are associated with H. pylori related GC progression and mortality in specific populations.